Perrigo (PRGO)
NYSEHealth CareDrug Manufacturers - Specialty & GenericSnapshot 2026-11-04
$15.83+0.83%
Close 2026-11-04 · 1-day change
NYSEHealth CareDrug Manufacturers - Specialty & GenericSnapshot 2026-11-04
QuarterlyIQ Insights · PRGO
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2016 | Dec 2015 | Dec 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||
| Revenues | 4,090.2 | 4,253.1 | 4,373.4 | 4,655.6 | 4,451.6 | 4,138.7 | 4,088.2 | 3,869.9 | 4,731.7 | 0.8 | 0.8 | 3,914.1 |
| Total Revenues | — | — | — | — | — | — | — | — | — | 0.8 | 0.8 | 3,914.1 |
| Cost of Revenues | 2,767.8 | 2,758.6 | 2,830.7 | 2,975.2 | 2,996.2 | 2,722.5 | 2,593.3 | 2,436.2 | 2,900.2 | 3,228.8 | — | 2,462.0 |
| Gross Profit | 1,322.4 | 1,494.5 | 1,542.7 | 1,680.4 | 1,455.4 | 1,416.2 | 1,494.9 | 1,433.7 | 1,831.5 | — | — | 1,452.1 |
| Operating Expenses & Income | ||||||||||||
| R&D Expenses | 92.0 | 95.4 | 112.2 | 122.5 | 123.1 | 122.0 | 121.7 | 119.2 | 218.6 | 184.0 | 187.8 | 152.5 |
| Other Operating Expenses, Total | — | (30.5) | (6.0) | 0.8 | (0.8) | — | — | — | — | — | — | — |
| Operating Income | (1,612.8) | (1,122.2) | 112.9 | 151.9 | 78.9 | 410.4 | 265.2 | 174.7 | 236.5 | (1,999.7) | 672.5 | 571.4 |
| Earnings from Continuing Operations | ||||||||||||
| Asset Writedown | 1,694.4 | 1,363.1 | 88.9 | 90.0 | 0.0 | 173.1 | 0.0 | 13.8 | 224.4 | 2,631.0 | — | — |
| EBT, Incl. Unusual Items | (1,653.0) | (1,297.9) | (80.7) | (8.3) | (139.1) | 258.7 | — | — | 290.6 | (4,848.3) | 260.3 | 303.6 |
| Income Tax Expense | 77.2 | 104.4 | 80.0 | (3.9) | (8.2) | 389.6 | (38.3) | (10.7) | 159.6 | (835.5) | 124.2 | 70.8 |
| Earnings from Continuing Operations | — | — | — | — | — | — | — | — | — | — | — | 205.3 |
| Net Income | ||||||||||||
| Net Income | (1,769.7) | (1,425.4) | (171.8) | (12.7) | (140.6) | (68.9) | (162.6) | 146.1 | 131.0 | (4,012.8) | 136.1 | 232.8 |
| Per Share | ||||||||||||
| Basic EPS | (12.70) | (10.29) | (1.25) | (0.09) | (1.04) | (0.52) | (1.20) | 1.07 | 0.95 | (28.01) | 0.97 | 2.02 |
| Diluted EPS | (12.70) | (10.29) | (1.25) | (0.09) | (1.04) | (0.52) | (1.19) | 1.07 | 0.95 | (28.01) | 0.97 | 2.01 |
| Revenue per Share | 29.34 | — | — | — | — | — | — | — | — | — | — | — |
| Dividend per Share | — | 1.16 | 1.10 | 1.09 | 1.04 | 0.96 | 0.90 | 0.82 | 0.76 | 0.58 | 0.46 | 0.39 |
| Basic Weighted Avg Shares | 139.4 | 138.5 | 137.4 | 135.3 | 134.5 | 133.6 | 136.1 | 136.0 | 137.8 | 143.3 | 139.3 | 115.1 |
| Diluted Weighted Avg Shares | 139.4 | 138.5 | 137.4 | 135.3 | 134.5 | 133.6 | 137.2 | 136.5 | 138.3 | 143.3 | 139.8 | 115.6 |
| Supplemental | ||||||||||||
| EBITDA | — | (784.7) | 438.8 | 511.4 | 417.5 | 707.2 | 552.9 | 471.8 | 660.1 | (1,542.7) | 931.2 | 777.5 |
| EBIT | (1,612.8) | (1,122.2) | 112.9 | 151.9 | 78.9 | 410.4 | 265.2 | 174.7 | 236.5 | (1,999.7) | 672.5 | 571.4 |
| Effective Tax Rate | -4.7% | — | — | 47.0% | 5.9% | 150.6% | — | — | 54.9% | 17.2% | 47.7% | 23.3% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.